Drug of the Month: Dabigatran

Posted by admin in News

Posted on Tuesday, October 25th, 2011 at 11:38 am

Dabigatran (Pradaxa) is a new oral anticoagulant that has recently been licensed for use in atrial fibrillation to prevent strokes.  Dabigatran is at least as effective as warfarin in reducing strokes in patients with atrial fibrillation.  An important advantage to warfarin is that dabigatran does not require regular blood tests like warfarin to stabilise the dose.  This is a welcome development, particularly for patients that have problems with regular blood tests and those that have erratic INR readings.  Dabigatran is now available in the UK if it is prescribed by a doctor.